NovoPath Cytology LIS
Cytology is Its Own Specialty.
Your LIS Should Treat It That Way.
Cytology labs run on a workflow no other specialty has. Screeners see cases first. Pathologists see the abnormals. CLIA workload limits govern how many slides a cytotech can read in a day. Bethesda codes structure every GYN report. Reflex to molecular happens on the fly. And every cyto case might have a matching histology case that needs to be correlated at the point of diagnosis.
NovoPath was built to change that.
Bethesda
Reporting structured
from the first click
CLIA
Workload tracked
automatically
99.9%
Uptime on cloud
infrastructure
Your Cytology Lab is Running on Software
That Was Built for Something Else.
Case volumes keep climbing. CLIA inspections keep coming. Referring OB-GYNs and clinicians expect faster turnaround. And every workaround your team has built to make an AP-first LIS handle cytology is a workaround your lab has to maintain forever.
The labs that get ahead in cytology are the ones running on infrastructure that understands the screener-first workflow, the CLIA workload requirement, and the Bethesda framework as core capabilities, not bolt-ons.
What We Hear from Cytology Labs Before They Make a Change.
Bethesda Lives in Free-Text Fields
Specimen adequacy, interpretation, grade, and additional findings get typed into notes instead of captured as discrete reportable data.
CLIA Workload Is a Spreadsheet Problem
Cytotechs manually log every case they read. Someone reconciles the spreadsheet at year-end. Inspectors ask for records. Everyone scrambles.
Reflex to Molecular Means Leaving the Case
When a Pap comes back abnormal, HPV results get pasted in later, and the correlation lives only in the pathologist's memory.
Cyto and Histo Get Read Separately
Cytology and histology from the same encounter get read by different pathologists, fragmenting the diagnosis before it ever leaves the lab.
NovoPath addresses all of this, not by adding complexity but by eliminating it.
Cytology Built Around How Your
Screeners and Pathologists Actually Work.
Bethesda Reporting, Structured from the First Click
NovoPath comes preloaded with Bethesda codes, so specimen adequacy, interpretation, grade, and additional findings are captured as discrete, reportable data rather than free text. Predefined codes and macros auto-populate the report fields, which cuts repetitive typing and keeps language consistent.
Screening and QC That Hold the Line
Cytotechs release routine cases directly; abnormals route automatically to the pathologist. Reviewer roles are configurable, cleanly separating screening-only from screening-plus-review. A review requested flag pushes any case into secondary review, and your standard QC percentage is built into the workflow.
CLIA Workload Recording, Without the Spreadsheet
Every case a cytotech reads is logged and scored using CLIA's workload point system in real time, tracking cumulative workload against the regulatory limit and keeping your records inspection-ready without the manual bookkeeping.

What Running Your Lab Feels Like With NovoPath.
Cytology Diagnostic Laboratory
A high-volume cytology lab came to NovoPath running Bethesda coding in free-text fields, tracking CLIA workload in spreadsheets, and manually correlating cyto and histo cases from the same encounter. Today, screeners and pathologists work from a single system built for cytology, workload records are inspection-ready without manual bookkeeping, and correlated cases are read together instead of separately.
Implementation Excellence:
Get It Right the First Time.
A successful transition begins with a structured, proven approach.
NovoPath will be on-site to see first-hand how your cytology workflows currently operate, from accessioning through screener review to pathologist sign-out.
We’ll work with you to map your GYN and non-GYN volumes, screener roles, CLIA workload configuration, and molecular reflex patterns to scope the future-state buildout.
After reviewing your resources and current environment, NovoPath will deliver a workflow analysis and an expected configuration plan tailored to your lab.
NovoPath will actively build the configurations required to match your Bethesda reporting standards, screener permissions, QC percentage, workload point calculation, and molecular integrations.
The team will conduct extensive testing and validation across reporting templates, workload calculations, and reflex routing prior to final delivery.
During delivery, we will work with you to issue the appropriate governances and permissions for screener and pathologist role separation.
SME-led validation sessions with your laboratory stakeholders to ensure the system accurately reflects real-world cytology operations.
End-to-end testing of core workflows, including accessioning, screener review, QC routing, reflex triggering, and inspection reporting in a controlled environment.
End-user training is conducted in parallel to ensure cytotechs, pathologists, and lab directors are confident and aligned before go-live.
Final production deployment of the validated system into the live laboratory environment.
Real-time go-live monitoring with dedicated support resources available to resolve issues immediately as users transition into production workflows.
Post-launch stabilization period focused on performance validation, user support, and rapid optimization to ensure full operational adoption and confidence.
300+
Labs Successfully Implemented
Almost without exception, labs that have made the switch tell us they wished they had done it sooner.
